Capture of Authentic Embryonic Stem Cells from Rat Blastocysts  by Buehr, Mia et al.
Capture of Authentic Embryonic
Stem Cells from Rat Blastocysts
Mia Buehr,1,2 Stephen Meek,1,2 Kate Blair,3,4 Jian Yang,3,5 Janice Ure,1 Jose Silva,3,4 Renee McLay,1 John Hall,3,4
Qi-Long Ying,1,6 and Austin Smith3,4,*
1Institute for Stem Cell Research, University of Edinburgh, King’s Buildings, Edinburgh EH9 3JQ, UK
2The Roslin Institute, University of Edinburgh, Roslin, Midlothian, EH25 9PS, UK
3Wellcome Trust Centre for Stem Cell Research, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK
4Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QW, UK
5The Key Laboratory of Molecular Medicine, Ministry of Education, Shanghai Medical College, Fudan University,
Shanghai, 200032, P.R. China
6Present address: Center for Stem Cell and Regenerative Medicine, Keck School of Medicine, University of Southern California,
Los Angeles, CA 90089, USA
*Correspondence: austin.smith@cscr.cam.ac.uk
DOI 10.1016/j.cell.2008.12.007SUMMARY
Embryonic stem (ES) cells have been available from
inbred mice since 1981 but have not been validated
for other rodents. Failure to establish ES cells from
a range of mammals challenges the identity of culti-
vated stem cells and our understanding of the plurip-
otent state. Here we investigated derivation of ES
cells from the rat. We applied molecularly defined
conditions designed to shield the ground state of
authentic pluripotency from inductive differentiation
stimuli. Undifferentiated cell lines developed that ex-
hibited diagnostic features of ES cells including colo-
nization of multiple tissues in viable chimeras. Defin-
itive ES cell status was established by transmission
of the cell line genome to offspring. Derivation of
germline-competent ES cells from the rat paves the
way to targeted genetic manipulation in this valuable
biomedical model species. Rat ES cells will also
provide a refined test-bed for functional evaluation
of pluripotent stem cell-derived tissue repair and
regeneration.
INTRODUCTION
Authentic ES cells are defined by three cardinal properties:
unlimited symmetrical self-renewal in vitro; comprehensive
contribution to primary chimeras; and generation of functional
gametes for genome transmission. ES cells are obtained from
pluripotent epiblast cells of the mouse blastocyst extracted
from the uterine environment and placed in the artificial context
of laboratory cell culture (Buehr and Smith, 2003; Evans and
Kaufman, 1981; Gardner and Brook, 1997; Martin, 1981). It is
unclear whether ES cells themselves arise as a consequence
of the synthetic culture milieu or represent a transient phase
in ontogeny that is captured by arresting developmentalprogression (Buehr and Smith, 2003; Gardner and Brook,
1997; Niwa, 2007; Silva and Smith, 2008; Smith, 2001a).
Empirical evidence to date is that ES cells can reproducibly be
derived from only a few inbred mouse strains. This is achieved
using fibroblast feeders and/or the cytokine leukemia inhibitory
factor (LIF) in combination with selected batches of fetal calf
serum or the growth factor bone morphogenetic protein (Gard-
ner and Brook, 1997; Ying et al., 2003a). The same conditions
do not yield ES cells from most mouse strains and not at all
from the rat (Brenin et al., 1997; Prelle et al., 1999). We (Buehr
et al., 2003) and others (Fandrich et al., 2002; Vassilieva et al.,
2000) have reported derivation of cell lines from preimplantation
rat embryos that have superficial morphological resemblance to
ES cells but do not express biologically relevant levels of the key
transcription factor determinants of ES cell identity, Oct4 (Niwa
et al., 2000) and Nanog (Chambers et al., 2003; Mitsui et al.,
2003), and are not capable of germlayer differentiation in vitro,
in tumors, or in chimeras. In our experience, such cells give
rise only to extraembryonic trophoblast and hypoblast lineages,
and we refer to them as extraembryonic stem (ExS) cells (Buehr
et al., 2003).
Shortly after implantation the epiblast transforms into an
epithelium and in rodents forms a cup-shaped structure termed
the egg cylinder. Cell lines termed EpiSCs have recently been
derived from the epithelialized epiblast of postimplantation
mouse and rat egg cylinders (Brons et al., 2007; Tesar et al.,
2007). These cells have fundamentally different growth factor
requirements from ES cells. They are sustained by fibroblast
growth factor (FGF) plus activin or nodal and not by LIF. In this
respect they resemble primate embryo-derived stem cells
(Thomson et al., 1998; Vallier et al., 2005; Xu et al., 2005). Like
primate stem cells and unlike ES cells, EpiSCs are sensitive to
single-cell dissociation and are generally passaged as clusters
of cells rather than dispersed. They do exhibit capacity for multi-
lineage differentiation and teratoma formation. Crucially,
however, EpiSCs fail to incorporate properly into the inner cell
mass (ICM) when injected into blastocysts and do not contribute
significantly to chimeras (Tesar et al., 2007).Cell 135, 1287–1298, December 26, 2008 ª2008 Elsevier Inc. 1287
Although the tissue and stage of origin of ES cells and EpiSCs
are defined, the identity between these cultured cell lines and
resident cells in the embryo is uncertain (Rossant, 2008). The
derivation of cell lines in culture may involve significant transcrip-
tional and/or epigenetic reprogramming, particularly when
potent stimuli such as FGF are involved. One example of this is
the reprogramming of unipotent primordial germ cells to
generate pluripotent EG cells (Durcova-Hills et al., 2006; Matsui
et al., 1992; Resnick et al., 1992). Derivation of tripotent neural
stem cells using FGF may be a similar instance (Gabay et al.,
2003; Pollard et al., 2008). However, the key parameter deter-
mining derivation and propagation of mouse ES cells appears
to be suppression or neutralization of extrinsic differentiation
signals (Ying et al., 2003a, 2008), rather than provision of a
self-renewal stimulus. Based on those findings we have postu-
lated that ES cells represent a ground state in mammalian devel-
opment and that this may be shared with preimplantation
epiblast cells (Silva and Smith, 2008).
An empirically determined culture construction that is effective
for derivation of ES cells only in specific inbred laboratory mouse
strains may actually be counterproductive for maintaining
ground state pluripotency more broadly. Serum and serum
substitutes contain a variety of inductive stimuli that may activate
commitment and differentiation programs. ES cells will continue
to proliferate in the absence of serum. However, simple with-
drawal of serum or other exogenous stimuli is not sufficient to
prevent differentiation because of the autoinductive action of
fibroblast growth factor 4 (FGF4) (Kunath et al., 2007; Stavridis
et al., 2007; Ying et al., 2003b). FGF4 signaling through the
MEK/ERK pathway drives ES cells into commitment. Genetic
impairment or selective chemical blockade of this pathway can
sustain self-renewal of mouse ES cells, even in the absence of
LIF signaling (Chen et al., 2006; Ying et al., 2008). However, to
suppress differentiation entirely and maintain high viability and
growth rate when FGF/ERK signaling is reduced it is necessary
either to provide LIF or to restrict activity of glycogen synthase
kinase 3 (GSK3). GSK3 is a central node for negative modulation
of a range of anabolic processes and generally acts to suppress
cellular biosynthetic capacity (Frame and Cohen, 2001). GSK3 is
inhibited by phosphorylation downstream of growth factors that
activate phosphatidyl inositol 3 kinase and Akt. GSK3 is also
a key component of the b-catenin destruction complex and
pharmacological inhibition of GSK3 increases cytoplasmic and
nuclear b-catenin, mimicking canonical Wnt signaling (Ding
et al., 2000). The small molecule CHIR99021 selectively inhibits
both GSK3a and GSK3b (Murray et al., 2004). The combination
of three inhibitors (3i) that target FGF receptor, MEK, and
GSK3 enables efficient derivation and propagation of germline-
competent ES cells from a range of mouse strains (Ying et al.,
2008) (J. Nichols and A.S., unpublished data). These findings
suggest that the key to deriving and maintaining ES cells may
be to shield the native epiblast ground state from activation of
the ERK pathway by either exogenous or autocrine inductive
stimuli that will normally drive developmental progression.
Complementary inhibition of GSK3 stabilizes the ground state,
likely via a combination of b-catenin-dependent action and
b-catenin-independent anabolic effects (Silva and Smith, 2008)
(J. Wray and A.S., unpublished data). To test the generality of1288 Cell 135, 1287–1298, December 26, 2008 ª2008 Elsevier Inc.this concept we have investigated the possibility of deriving
true ES cells from the rat.
RESULTS
Sustained Expression of Pluripotent Markers in Rat
Inner Cell Masses Explanted in 3i
We first examined the effect of the neutralizing 3i culture regime
on ICMs explanted from rat blastocysts. In addition to 3i we
provided LIF because although this is dispensible for mouse
ES cell culture in 3i, we find that clonogenicity and ES cell deri-
vation are invariably enhanced by addition of LIF (Ying et al.,
2008) (J. Wray, J. Nichols, and A.S., unpublished data). As
a source of LIF we used DIA-M feeders that have been geneti-
cally engineered to express the matrix-associated form of LIF
(Buehr et al., 2003; Rathjen et al., 1990b). The feeders also
support attachment of the ICMs.
Retained expression of the transcriptional determinant Oct4
can be used as a surrogate assay for presence of pluripotent
cells (Buehr et al., 2003). In ICM explants in conventional culture
Oct4 is rapidly extinguished (Buehr and Smith, 2003). ICMs were
isolated from embryonic day (E) 4.5 rat blastocysts by immuno-
surgery and plated on DIA-M feeders. Explants were fixed at
different time points and analyzed by immunostaining
(Figure 1A). In standard culture with or without serum we
observed loss of Oct4 by 3 days as previously described (Buehr
et al., 2003). Concurrent with downregulation of Oct4 we noted
ectopic appearance of Cdx2, the trophectoderm determinant
and antagonist of Oct4 (Niwa et al., 2005). Expression of Oct4
and Cdx2 were generally mutually exclusive. In contrast, in the
presence of 3i we found that Oct4 protein was maintained in
the majority of cells after 3 days and expression of Cdx2 was sup-
pressed. By 4 days the majority of cells in the core of the explants
were Oct4 positive (Figure 1B). A second critical marker of plurip-
otent status, Nanog (Chambers et al., 2003; Mitsui et al., 2003),
which is downregulated in similar fashion to Oct4 in conventional
culture, was similarly maintained in serum-free medium supple-
mented with 3i, although with a more heterogeneous expression
than Oct4. The effect of 3i is unlikely to be due to cell selection
because the total number of ICM cells was actually higher in
the 3i-treated cultures (Table S1 available online).
We then dissociated ICMs cultured in 3i for 3 days into small
clumps and replated them in the same conditions. Cells re-
mained viable and formed colonies of morphologically undiffer-
entiated cells. These colonies continued to express Oct4 and
Nanog (data not shown). In many previous experiments under
various conditions (Buehr et al., 2003; Buehr and Smith, 2003),
we have very rarely detected expression of Oct4 after replating
and only confined to small clusters of cells, never throughout
the outgrowths as seen in 3i. These observations suggest that
3i may suppress loss of pluripotency and differentiation of
cultured rat epiblast.
Derivation of Continuous Cell Lines
We therefore investigated longer-term effects. ICMs from two
different inbred strains, Dark Agouti (DA) and Fischer 344, were
plated on DIA-M feeders in serum-free 3i. After 3–4 days, around
one-third of the ICMs had attached and proliferated such that
Figure 1. Inhibitors Sustain Expression of Pluripotency Markers in Rat ICM Primary Explants and Expanded Cell Lines
(A) Oct4 and Cdx2 immunofluorescence staining of ICM explant cultured in the presence of serum or in serum-free 3i for 3 days. Arrows indicate feeder cell nuclei.
(B) Oct4 and Nanog immunostaining of ICM after 4 day culture in 3i, detached from feeders for fixation and staining.
(C) Immunofluorescent staining of Oct4 and Nanog in established 3i cell line.
(D) RT-PCR analysis of pluripotent marker expression in expanded 3i cell lines compared with E14Tg2a mouse ES cells (mES), rat ExS cells (rExS), and rat ExS
cells expressing mouse Oct and mouse Nanog (rExS + mO/mN) transgenes.
(E) RT-PCR analysis of differentiation marker expression in expanded 3i cell lines. cDNA from an E10.5 rat embryo provides a positive control.they could be mechanically broken up into small clumps and re-
plated in fresh wells. From one in three of these replated ICMs,
small colonies of undifferentiated morphology developed. These
colonies became large enough for manual transfer into new wells
after 10 days. After a further few days they were dissociated
manually and replated, invariably giving rise to multiple undiffer-
entiated colonies. Thereafter cultures could be passaged
repeatedly. We established twenty cell lines in this way from
three independent experiments (Table 1A).
All lines were similar in morphology and growth characteris-
tics. They proliferate as clumps of tightly packed cells, similar
to mouse ES cells cultured in 3i (Ying et al., 2008). Individual cells
have the high nucleus to cytoplasm ratio and prominent nucleoli
characteristic of ES cells. They are apolar and lack processes,
cytoarchitectural features, or other signs of specialization. Colo-
nies have a tendency to detach from the feeder layer if theybecome too large, and cells were therefore routinely passaged
every 3–4 days. The colonies can readily be dissociated by
gentle trituration or enzymatically using Accutase. After dissoci-
ation, single cells isolated by micropipette readily give rise to
undifferentiated colonies that can be serially passaged. Cells
can be cryopreserved and recovered by conventional proce-
dures using DMSO as cryoprotectant. Cultures have been
expanded continuously for 6 months with no discernible change
in growth rate, no indications of crisis or senescence, and little
overt differentiation in presence of 3i.
Characterization of 3i Rat Cell Lines
To assess the identity of 3i rat cells we examined expression of
key markers of pluripotency and lineage commitment. Nuclear
localized Oct4 and Nanog proteins were detected by immunoflu-
orescence microscopy (Figure 1C). RT-PCR analyses confirmedCell 135, 1287–1298, December 26, 2008 ª2008 Elsevier Inc. 1289
expression of these genes along with other ES cell markers,
Rex-1, Errb, Sox2, Eras, Stella, and the Oct4/Sox2 target Fgf4
(Figure 1D). To control for the possibility of crosscontamination
with mouse ES cells or cDNA, primers for amplification of Nanog
were designed against sequences specific for the rat gene.
These primers consistently yielded products of anticipated size
from rat cells but not from mouse ES cells. Conversely,
mouse-specific primers did not yield any product from the rat
cells. We also evaluated expression of differentiation markers.
Transcripts for the hypoblast and definitive endoderm markers
Gata6 and Sox17, the mesoderm markers brachyury and Flk1,
or the neuroectoderm markers Pax6 and nestin were low or
undetectable (Figure 1E).
We found that undifferentiated cells could not be maintained
when withdrawn from 3i. They underwent cell death and
surviving cells differentiated into heterogeneous morphologies
accompanied by loss of expression of Oct4 and Nanog (Figures
2A and 2B). LIF showed little or no capacity to block this differ-
entiation in either the presence or absence of feeders or serum.
We tested whether 3i cells could be sustained in the specific
growth conditions that are employed to propagate EpiSCs. Rat
3i cells differentiated when 3i was replaced with activin plus
FGF2 (Brons et al., 2007), whether on feeders or fibronectin-
coated dishes (Figure 2C). Furthermore, the activin receptor
inhibitor SB431452, which induces differentiation of EpiSCs
(Brons et al., 2007) but not of mouse ES cells, did not impede
expansion of undifferentiated 3i rat cells. We also tested whether
blastocyst-derived rat ExS cells (Buehr et al., 2003) could be
maintained in 3i and found that they do not survive.
A hallmark of female ES cells and early epiblast is that both X
chromosomes are active (Mak et al., 2004; Okamoto et al., 2004;
Table 1. Derivations in 3i and 2i
(A) Derivation of Undifferentiated Cell Lines in 3i
Strain No. of ICMs Outgrowths Continuous
Expt 1 F 47 18 8
‘‘ DA 29 6 2
Expt 2 F 30 11 6
‘‘ DA 11 2 0
Expt 3 F 24 7 1
‘‘ DA 24 16 3
Total F + DA 165 60 20
(B) Derivation of Rat ES Cells in 2i
Strain No. of ICMs Outgrowths Continuous
Expt 1 F 47 34 28
Expt 2 DA 67 50 43
Expt 3 F + DA 114 84 71
Expt 4 SD 7 6 2
Total F + DA + SD 235 174 144
Outgrowths refers to adherent primary explants. Continuous refers to
proliferating cultures of undifferentiated cells after three passages.
Many cultures were passaged further and in no case did a culture
collapse to differentiation, growth arrest, or cell death if undifferentiated
after three passages.
F, Fischer 344; DA, DA; SD, Sprague-Dawley.1290 Cell 135, 1287–1298, December 26, 2008 ª2008 Elsevier Inc.Rastan and Robertson, 1985). Upon proper differentiation one X
chromosome then becomes silenced (Wutz and Jaenisch, 2000).
We stained XX 3i rat cells with an antibody against trimethylated
histone 3 lysine 27 (H3K27), an epigenetic silencing mark that
decorates the inactive X chromosome in interphase nuclei (Silva
et al., 2003). Cells maintained in 3i showed diffuse immunoreac-
tivity throughout the nucleus whereas cells differentiated by
withdrawal of 3i in serum for 6 days exhibited a prominent focus
of nuclear staining diagnostic of the inactive X (Figure 2D). These
data indicate that in undifferentiated XX 3i rat cells both X chro-
mosomes lack a global epigenetic silencing mark and that one X
chromosome acquires this modification during differentiation.
EpiSCs in contrast exhibit X inactivation (G. Guo and A.S.,
unpublished data), consistent with egg cylinder origin. Thus 3i
rat cells exhibit a unique epigenetic feature of early epiblast
and ES cells.
To investigate differentiation potential we injected both DA-
and Fischer-derived lines under the kidney capsule of immuno-
deficient SCID mice. After 30–55 days, animals were sacrificed.
Seven out of eleven exhibited a macroscopic tissue mass,
varying in size from less than a gram to over 4 g, at the site of
the injection. Histological analyses of two specimens, one from
each line, revealed classical features of a teratoma, with multiple
differentiated cell types and structures including striated muscle,
bone, cartilage, keratinized epithelia, secretory epithelia of the
gut, and others (Figure 2E and data not shown). We conclude
that 3i rat cell lines are capable of producing teratomas and
are competent for mature multilineage differentiation.
Rat 3i Cells Contribute to Chimeras
The above findings indicate that 3i cells are significantly different
from previously described cell lines from rat embryos. However,
the essential attribute of authentic ES cells is their capacity to
colonize host embryos and contribute differentiated progeny to
all germlayers plus the germlines of chimeric animals (Smith,
2001b). Following lipofection and selection in puromycin we
derived a pool of stably transfected cells that expressed green
fluorescent protein (GFP) (Figure S1). These cells were injected
into blastocysts. Embryos harvested at E10.5 and at E13.5
showed widespread contribution of GFP-labeled cells (Figures
3A and 3B). Examination of vibratome sections confirmed distri-
bution in all three germlayers. An E13.5 chimera was analyzed for
contribution to primordial germ cells. Immunostaining of genital
ridges for Oct4 and vasa homolog revealed coexpression with
GFP, indicating that 3i cells can colonize the developing germline
(Figure 3C).
We then examined potential to contribute to postnatal
chimeras. Five overt coat color chimeras were born after injec-
tion of a GFP-labeled DA line into albino Fischer blastocysts.
However, these animals either died perinatally or were eutha-
nized prior to weaning due to jaw abnormalities (see below). Un-
fixed tissue squashes from one of the neonates showed GFP
fluorescence in skin, lung, liver, and kidney (Figure 3D). Vibra-
tome sections from a P25 chimera also revealed GFP-positive
cells in a variety of tissues, including testis. Based on
morphology and location, expression in the testis appeared to
be in spermatogonial cells in addition to somatic sertoli and
myoid cells (Figure 3E). Fluorescent spermatocytes were not
evident, however (see below).
We also injected unmodified cells into blastocysts. Of 27
animals born after injection of Fischer cells into DA hosts, all
were agouti with no detectable albino contribution. In contrast,
from injections of DA cells into Fischer blastocysts two liveborn
animals exhibited mixed agouti and albino coloring (Figure 3F).
Both animals were heavily pigmented with the albino host con-
tribution apparent only on the head. This skewed pattern is
characteristic of rat chimeras between albino hooded and fully
pigmented strains and does not correlate with overall contribu-
tions (Yamamura and Markert, 1981). Microsatellite analyses
of tail, ear, and blood biopsies confirmed the chimeric nature
of these animals (Figure 3G) and quantified the respective DA:
Fischer contributions as approximately 75:25 and 25:75 in the
two animals (Figure S2). Both chimeras developed into healthy
adults.
Breeding from these DA:Fischer chimeras failed to yield trans-
mission of the DA cell line genome, however. We then found in
the course of cytogenetic characterization that all 3i lines
analyzed were XX. Since both chimeras were male they could
not support development of spermatocytes from the introduced
cells, which would explain the absence of germline transmission
and the restricted GFP staining in the chimeric testis (Figure 3E).
Figure 2. Differentiation of Rat 3i Cells In Vitro and in
Teratomas
(A) Undifferentiated cells in 3i (left) and cells differentiated after
withdrawal of inhibitors for 7 days on fibronectin in the absence
of serum (right).
(B) Downregulation of Oct4 and Nanog immunostaining upon
differentiation on feeders in serum.
(C) 3i cells differentiate in the presence of activin and FGF on
feeders.
(D) Immunofluorescence for me3H3K27 (green) in undifferentiated
cells and after differentiation for 6 days in serum. Undifferentiated
cells show diffuse staining while differentiated cells exhibit a prom-
inent H3K27me3 nuclear body. Cells were counterstained with
DAPI (blue).
(E) Histological sections of teratomas derived from Fischer and DA
3i cell lines showing keratinized epithelium, striated muscle, and
gut epithelium.
Of greater concern, however, was detection in two
of the lines, including the GFP-labeled line that gave
abnormalities in chimeras, of trisomy for chromosome
9. This was revealed by array-based comparative
genome hybridization (aCGH) and confirmed by fluo-
rescence in situ hybridization (FISH) (Figure S3 and
data not shown). The sex bias and the chromosomal
anomalies raised the possibility of inadvertent selec-
tion pressure during derivation and/or expansion of
rat cells in 3i.
Derivation of Germline-Competent Rat Cells
Using Two Inhibitors
We considered that application of the FGFR inhibitor
SU5402 may not be optimal because it is less specific
than the MEK and GSK inhibitors. An additional factor
is that the effect of blocking FGFR is not restricted to the MEK/
ERK cascade but will also reduce activation of phosphatidylino-
sitol 3-kinase and other pathways downstream of FGFR that
might be beneficial for ES cells. Accordingly we omitted
SU5402 and switched to a two inhibitor (2i) formulation
comprised of the more potent MEK inhibitor PD0325901 (Bain
et al., 2007) with the GSK3 inhibitor. We have found that 2i
supports clonogenic expansion of mouse ES cells more effi-
ciently than 3i (Ying et al., 2008). Additionally, 2i facilitates isola-
tion of induced pluripotent stem (iPS) cells during transfection-
induced reprogramming (Silva et al., 2008).
Rat ICMs cultured in 2i on DIA-M feeders attached and yielded
expandable undifferentiated cell lines at increased frequency
compared with 3i cultures (Table 1B). The 2i cells were morpho-
logically indistinguishable from lines derived in 3i (Figure 4A) and
could similarly be expanded and cryopreserved. Consistent with
the high frequency of derivation many of these 2i isolations gave
positive PCR amplification of the Y chromosome-specific Sry
locus (Figure S4). Metaphase spreads prepared from 12 lines
all displayed a mixture of metacentric, telocentric, and acrocen-
tric chromosomes characteristic of the rat and distinct from the
telocentric chromosomes found in mice. Counts gave a modal
chromosome number of 42. FISH analyses confirmed the
absence of chromosome 9 amplifications in all 12 linesCell 135, 1287–1298, December 26, 2008 ª2008 Elsevier Inc. 1291
Figure 3. Contribution of 3i Cells to Chimeras and Colonization of Germline
(A) Bright-field and fluorescence images of E13.5 chimeric embryo.
(B) Vibratome slices through whole E10.5 chimera GFP fluorescence in green, DAPI nuclear staining in blue.
(C) GFP expression in Oct4 and vasa homolog positive primordial germ cells of E13.5 chimera. Arrowheads point to cells coexpressing GFP and vasa homolog.
(D) GFP expression in unfixed tissue squashes from neonatal chimera.
(E) GFP expression in vibratome section of testis from P25 chimera. GFP is apparent in Sertoli cells, myoid cells, and spermatogonia but absent from spermato-
cytes.
(F) Adult coat color chimeras derived from 3i cells. White snouts denote the recipient Fischer strain (hooded albino), body pigmentation the cell line DA strain.
(G) Microsatellite analyses of adult coat color chimeras. Polymorphic regions D1Rat122 and D3Rat17 were amplified by PCR from genomic DNA of tail, ear, and
blood.(Figure 4B). aCGH analysis substantiated rat identity and the
absence of any major deletions or amplifications (Figure S3).
After expansion for five or six passages we attempted to
generate chimeras from four of the 2i rat lines. Coat-color
chimeras were obtained from injection of three DA lines into
Fischer blastocysts (Table 2). All developed into healthy adults.
We confirmed cell line contribution of approximately 50% by mi-
crosatellite analysis of one chimera (Figure S5). These lines all
turned out to be female, however, and breeding from the female
chimeras has so far failed to yield offspring with cell line genome.
We also injected a male line, SD2, derived from the albino
Sprague-Dawley strain, into blastocysts from the pigmented
DA strain. We obtained a healthy male chimera (Figure 4C).
This animal has been mated to Fischer females. To date he
has sired 89 agouti pups and 13 healthy albino offspring
(Figure 4D). Recessive albinos should only arise from SD2-
derived sperm. Microsatellite analyses provide molecular valida-1292 Cell 135, 1287–1298, December 26, 2008 ª2008 Elsevier Inc.tion that these animals are indeed Sprague-Dawley 3 Fischer
hybrids (Figure 4E). We conclude that the cultured cell genome
is transmitting reproducibly though the chimeric male germline.
2i Rat Cells Exhibit In Vitro Properties and Behavior
of Embryonic Stem Cells
We then examined the properties of 2i rat cells relative to charac-
teristics expected for embryonic stem cells based on the mouse.
We first examined culture without feeders. Rat 2i cells did not
adhere to uncoated or gelatin-coated plastic but did attach to
fibronectin- or laminin-coated plates. They tended to detach
from fibronectin as colonies expanded but could be reliably
maintained on laminin in the presence of 2i plus LIF. Colonies
adopted a more flattened morphology (Figure 5A) than on
feeders, but they retained expression of nuclear Oct4 and Nanog
proteins (Figure 5B). Furthermore, they rapidly reverted to tightly
packed three-dimensional colony growth when returned to
feeders, even after multiple passages on laminin.
Cell-surface immunofluorescence staining revealed that 2i rat
cells propagated on laminin show a SSEA-1 profile similar to
mouse ES cells (Figure S7). Propidium iodide staining revealed
that more than 50% of cells are in S phase, a cell-cycle profile
shared with mouse ES cells (Figure 5C) and distinct from most
somatic cells that tend to reside in G1 (Burdon et al., 2002).
Figure 4. Rat Cells Derived in 2i Contribute to Chimeras and Give
Germline Transmission
(A) Morphology of 2i colonies on feeders at low and high magnification.
(B) FISH for chromosomes 9 and X on metaphase spread from DA 2i cell line.
(C) Microsatellite D3Rat17 analysis of SD2 chimera and non-chimeric litter-
mate.
(D) SD2 chimera and first albino offspring at 10 weeks of age (left), second
albino germline pup and two littermates at weaning (right).
(E) Analysis of four albino SD2 offspring and agouti littermates for polymorphic
region D2Rat250. The two albino germline pups exhibit both Fischer and
Sprague-Dawley amplicons. Their agouti littermates show very weak signals
for the Fischer D2Rat250 region because this amplification is suppressed in
the presence of the DA amplicon (Figure S6). Agouti genotypes were indepen-
dently confirmed as DA3 Fischer by amplification of D1Rat122, which reliably
amplifies and discriminates DA and Fischer, though not Sprague-Dawley (data
not shown).We examined a range of transcripts associated with the plurip-
otent ES cell phenotype (Takahashi and Yamanaka, 2006) or with
lineage commitment. Data in Figure 5D show that 2i rat cells
passaged on laminin in 2i plus LIF express a repertoire of pluripo-
tency markers similar to mouse ES cells and lack markers of
differentiation, alpha-fetoprotein (Afp), and T-brachyury. As
with 3i cells they express genes that discriminate between ES
cells and EpiSCs, such as Klf4, Rex1, and Stella.
A characteristic of mouse ES cells is responsiveness to LIF
acting via STAT3 (Burdon et al., 1999; Matsuda et al., 1999;
Niwa et al., 1998). In contrast to its potent effect on strain 129
mouse ES cells, LIF did not prevent differentiation of 2i rat cells
upon withdrawal of inhibitors, even in the presence of feeders
or serum. However, 2i alone was also not sufficient to sustain
self-renewal and cultures collapsed after the first passage
without LIF unless cells were kept at very high density. Since au-
tocrine LIF signaling can be anticipated at high cell densities
(Rathjen et al., 1990a) we investigated colony formation from
dissociated single cells. Very few colonies formed without LIF.
In contrast numerous colonies grew up in the combination of 2i
plus LIF (Figure 5E). When fixed and stained after 8 days, 50%
of the colonies contained a central mass of alkaline phospha-
tase-positive morphologically undifferentiated cells (Figure 5F).
We then examined induction of two well-characterized LIF target
genes. Egr1 is downstream of the Erk signaling arm, andSocs3 is
a direct target of STAT3 (Burdon et al., 1999). LIF was withdrawn
for 6 hr then added back for 1 hr, with or without 2i. In rat cells
and mouse ES cells, both genes were induced in the absence
of inhibitors confirming LIF signal responsiveness (Figure 5G).
In the presence of 2i, however, expression of Egr1 was sup-
pressed while Socs3 induction was unaffected. This is consis-
tent with inhibition of MEK/ERK signaling without affecting
STAT3 activation by 2i (Ying et al., 2008) and indicates that
STAT3 is the critical mediator of LIF action, as in mouse ES cells.
On exposure to serum in the absence of feeders, 2i, and LIF,
cells differentiated (Figure 5H). This was accompanied by down-
regulation of Nanog and Oct4 (Figure S8) and upregulation of
Gata6, Sox17, and Afp (Figure 5I). These are markers of both
hypoblast and definitive endoderm, though the nonepithelial
Table 2. Generation of Chimeras from 3i and 2i Rat ES Cells
Inhibitor
Medium Cell Line
Strain
and Sex
Injected
Embryos
Foetal
Chimeras
Term
Chimeras
3i 148C DA, \ 41 N/A 2_
3i 148D-GFP DA, \ 46 5 N/A
3i DA3-GFP DA, \ 80 1 5a
2i DA8 DA, \ 23 N/A 1\, 2_
2i DA13 DA, \ 21 N/A 1\
2i DA15 DA, \ 22 N/A 1\, 1_
2i SD2 SD, _ 12 N/A 1_
N/A, not applicable. DA (pigmented) cells were injected into Fischer
(albino) host blastocysts; SD (albino) cells into DA hosts. For 148C injec-
tions naturally mated recipients were used for blastocyst transfer. In other
cases pseudopregnant recipients were used.
a Three died neonatally, two sacrificed at 25 days due to jaw deformity.Cell 135, 1287–1298, December 26, 2008 ª2008 Elsevier Inc. 1293
Figure 5. Rat 2i Cells Exhibit Properties of Embryonic Stem Cells
(A) Undifferentiated morphology on laminin in 2i plus LIF (passage 3).
(B) Oct4 and Nanog immunostaining in 2i plus LIF on laminin (passage 3).
(C) Cell-cycle profile determination by flow cytometric analysis of propidium iodide staining.
(D) RT-PCR analysis of pluripotent and germlayer markers in mouse ES cells and two independent rat cell lines after two (SD2) or three (DAX11) passages on lam-
inin in 2i/LIF. Controls are rat neural stem (rNS) cells and whole E9.5 embryo. Except for Nanog, primers were selected for crossreaction on mouse and rat cDNA.
(E) Colony formation by dissociated single cells on laminin. Qualitatively similar results were obtained for several different cell lines.
(F) Typical alkaline phosphatase-positive colony showing undifferentiated core with differentiated cells on periphery.
(G) LIF induction of Stat3 target Socs3 but not of Erk target Egr1 in 2i for rat and mouse ES cells. Rat data are mean ± SD of two biological samples each assayed
in duplicate; mouse data are averages of technical duplicates from one experiment.1294 Cell 135, 1287–1298, December 26, 2008 ª2008 Elsevier Inc.
morphology is suggestive of the former. Neither cell fate is
readily obtained from mouse ES cells in adherent culture in
serum, but it is noteworthy that in contrast to the mouse, epiblast
cells in the rat have the ability to regenerate hypoblast (Nichols
et al., 1998).
We investigated whether rat 2i cells may follow autoinductive
differentiation into neuroectodermal lineages in serum-free
culture (Kunath et al., 2007). Cells were plated overnight in 2i/
LIF then cultured in unsupplemented N2B27 (Ying and Smith,
2003). Ten days later cultures were dominated by cells express-
ing the neural precursor marker nestin or immunoreactive for the
early neuronal marker TuJ1 (Figure 5K). Nestin-positive cells
were typically in rosette structures characteristic of neuroepithe-
lial cells while TuJ1-positive cells generally exhibited extended
processes expected for neuronal cells. Similar results were ob-
tained for four independent 2i cell lines.
Finally, we tested whether rat 2i cells could be stably trans-
fected by electroporation, the favored method of introducing
DNA constructs for homologous recombination into mouse ES
cells. Cells (1 3 106) were electroporated in the presence of
10% serum with 5, 20, or 50 mg linearized pPyCAGgfpIP plasmid
(Chambers et al., 2003). At least 50% of cells survived electropo-
ration and were plated overnight on DIA-M feeders in 2i medium
plus 5% serum to aid viability. The following day the medium was
changed to serum-free 2i. Puromycin (1 mg/ml) was added 72 hr
after electroporation. The number of puromycin-resistant colo-
nies increased with DNA concentration. With 50 mg of plasmid,
315 colonies were obtained after 8 days from 5 3 105 cells
plated, an efficiency of 0.05%. Fluorescent colonies were picked
into 96-well plates then expanded in dishes and success-
fully frozen/thawed without loss of GFP expression (Figure 5K).
Chromosomal integration was confirmed by genomic PCR
(Figure S9).
DISCUSSION
Collectively these findings demonstrate that application of 3i/2i
plus LIF enables the derivation of rat cell lines with the expected
properties of authentic ES cells: long-term self-renewal, pluripo-
tency, teratoma formation, capacity for incorporation into the
developing embryo, colonization of the germline, and generation
of functional gametes. Although the incidence of germline trans-
mission has been low to date, this is also typical of mouse ES
cells unless C57BL/6 strain blastocysts are used as hosts for
chimera production (Schwartzberg et al., 1989; Seong et al.,
2004). Systematic screening of different donor and host strain
combinations may give a preferred combination for production
of germline chimeras in the rat.
The 3i and 2i rat ES cells express the key molecular markers
found in mouse ES cells, Nanog, Oct4, Sox2, and Klf4. They
are therefore potentially maintained by the same transcription
factor circuitry (Chen et al., 2008; Kim et al., 2008). A recent
report claims derivation of rat ES cells in conventional ES cell
cultures with feeders, LIF, and serum (Ueda et al., 2008).
However, consistent with many previous reports we find that
these conditions are not adequate to derive or maintain rat ES
cells. Furthermore the cell-surface and marker profiles reported
by Ueda and colleagues are inconsistent with ES cell identity and
suggest that their cells may be EpiSC like.
The 3i/2i rat ES cells express Klf4, Stella (Pgc7, Dppa3), and
Rex1 (Zfp42), which discriminate ES cells from EpiSCs (Jiang
et al., 2008; Tesar et al., 2007). They differentiate in the presence
of serum and in the specific growth conditions used for EpiSCs.
Conversely, EpiSCs are dependent on FGF/Erk signaling and
rapidly die or differentiate in the presence of MEK inhibitor
(G. Guo and A.S., unpublished data). A further distinction from
EpiSCs is the absence of an X chromosome epigenetic silencing
mark in female 2i/3i cells. Finally, and most importantly, the rat
cells we have derived colonize the epiblast and contribute to
chimeras.
Significantly, 2i/3i rat cells are responsive to LIF, although LIF
alone is insufficient to sustain self-renewal. Mouse ES cells
derived from non-129 genetic backgrounds are also dependent
on factors in addition to LIF to sustain self-renewal, notably inhi-
bition of MEK/ERK (Batlle-Morera et al., 2008; Buehr and Smith,
2003; Ying et al., 2008). This insufficiency is likely to be a key
factor in previous failures to derive rat ES cells. Nonetheless,
rat ES cells are dependent on LIF/Stat3 signaling, another clear
distinction from EpiSCs. An interesting question for future inves-
tigation is whether there are qualitative or quantitative differ-
ences in LIF signaling between strain 129 mouse ES cells and
ES cells from other strains and species. We speculate that LIF/
Stat3 responsiveness may be a general feature of authentic ES
cells.
Cell lines derived in 3i exhibited an unexpected sex bias. More
worryingly, we detected in two independent lines trisomy for
chromosome 9. In 2i derived lines, in contrast, we were able to
derive equivalent numbers of male and female lines, and we
have so far not observed any chromosomal anomalies. However,
we have observed that both 3i and 2i rat ES cells are more sensi-
tive than standard mouse ES cells, requiring fastidious quality
control of tissue culture media for good viability and proliferation.
Therefore factors other than the use of SU5402 may have
contributed to either the sex bias or the trisomy. Furthermore,
we suspect that male cell lines may take longer to emerge and
could thus have been overlooked in our early studies. Nonethe-
less, it is advisable to dispense with an inhibitor such as SU5402
if it confers no obvious benefit.
The derivation of rat ES cells opens the door to application of
gene targeting and related genome engineering technologies in
the model species of choice for many aspects of biomedical
research. Physiological interventions, toxicology studies, and
evaluation of higher-order functions such as behavior and cogni-
tion are in general more sophisticated and informative in rats
(H) Differentiated morphology of 2i cells after 6 days culture in serum without 2i/LIF.
(I) RT-PCR analysis of marker expression during differentiation in serum.
(J) Immunostaining for nestin and TuJ1 after 10 days of adherent serum-free differentiation on laminin. Insets show higher-power images of nestin (upper) and
TuJ1 (lower) staining.
(K) Expression of GFP in stable transfectant clone generated by electroporation and expanded after puromycin selection and freeze/thawing.Cell 135, 1287–1298, December 26, 2008 ª2008 Elsevier Inc. 1295
than in mice. The observation that rat ES cells can be stably
transfected by electroporation is significant for future genetic
modification studies. Availability of rat ES cells also increases
the scope for testing the capacity of in vitro ES cell differentiation
to produce cells that can integrate and function in adult tissue
repair and regeneration.
Finally, effective preservation of ground state pluripotency in
cultured rat embryo cells using neutralizing 3i/2i culture suggests
that derivation of ES cells may indeed represent the capture of
resident embryo cells rather than a tissue culture artifact. This
points to an underlying conservation in the essential nature of
the pluripotent state in rodent embryos and potentially in other
mammals. We suggest that isolation of ES cells may represent
a simple continuation of early epiblast replication in the absence
of inductive signals (Silva and Smith, 2008) rather than require
transcriptional or epigenetic reprogramming (Buehr and Smith,
2003; Chou et al., 2008). This raises the possibility that culture
formulations based on the 3i/2i principle could facilitate deriva-
tion of ES cells from other mammals, including livestock species.
It will also be of interest to investigate whether supernumerary
human embryos cultured in 3i/2i may give rise to pluripotent
cell lines that are qualitatively different from current human
‘‘embryonic stem’’ cells and closer to ground state rodent ES
cells than to EpiSCs (Silva and Smith, 2008).
EXPERIMENTAL PROCEDURES
Details of RT-PCR, microsatellite analysis, cytogenetics, aCGH, transfections,
and immunostaining are provided in the Supplemental Data.
Culture Procedure
Feeder cells were prepared from gamma-irradiated or mitomycin-C-treated
DIA-M mouse fibroblasts that express matrix-associated LIF (Buehr et al.,
2003; Rathjen et al., 1990b). ICMs and passaged cell lines were plated on
DIA-M feeders in N2B27 medium (Ying and Smith, 2003) containing either 3i
(FGF receptor inhibitor SU5402, 2 mM; inhibitor of MEK activation
PD184352, 0.8 mM; GSK3 inhibitor CHIR99021, 3 mM) or 2i (MEK inhibitor
PD0325901, 1 mM; GSK3 inhibitor CHIR99021, 3 mM) (Ying et al., 2008) plus
human LIF (100 U/ml) prepared in-house (Smith, 1991). SU5402 was obtained
from Calbiochem; other inhibitors were custom-synthesized by the Division of
Signal Transduction Therapy, University of Dundee. Cell lines were routinely
passaged by aspirating the colonies into fine pipettes and transferring the
resultant disaggregated cells to fresh plates or by dissociation with Accutase.
Feeder-free culture was performed on plates pre-coated with laminin, 10 mg/ml
(Sigma). Monolayer neural differentiation was induced by adherent serum-free
culture in N2B27 for 10 days without inhibitors or LIF, essentially as described
for mouse ES cells (Ying et al., 2003b) except that laminin was used as
a substrate for attachment.
Chimera Generation
Rat blastocysts at E4.5 days post coitum (dpc) were collected by noon on the
day of injection and cultured for 2–3 hr in KSOM medium to ensure cavitation.
Cells were disaggregated in Accutase and 10–12 cells injected into the blasto-
cyst cavities. Injected embryos were transferred into uteri of naturally mated or
pseudopregnant Fischer F344 females according to availability of vasecto-
mized males.
Immunosurgery
Zonae were removed from E4.5 rat blastocysts with acid Tyrodes, and blasto-
cysts incubated at 37C in 20% anti-rat whole serum (Sigma) for 3 hr. Blasto-
cysts were washed and incubated for 20 min in rat serum as a source of
complement, and the lysed trophectoderm removed by pipetting.1296 Cell 135, 1287–1298, December 26, 2008 ª2008 Elsevier Inc.Teratoma Generation
Approximately 200–400 cells were injected under kidney capsules of SCID
mice (BALB/c JHan Hsd-Prkdc scid.). Tumors were collected at various times,
and their weight determined by weighing tumor and kidney and subtracting the
weight of the contralateral uninjected kidney. Tumors were embedded in
paraffin wax, sectioned, and stained with Masson’s trichrome.
Electroporation
13 106 2i rat ES cells were electroporated in N2B27 + 10% FCS with 5, 20, or
50 mg ScaI linearized pPCAGgfpIP plasmid using the Bio-Rad Genepulser
apparatus (0.8 kV, 3 mF). 63 105 electroporated cells were plated into a 10 cm2
well containing 2i medium + 5% FCS. The following day the medium was
changed to serum-free 2i. 1 mg/ml puromycin selection was added 72 hr
post-electroporation and the number of puromycin-resistant colonies counted
8 days post-electroporation. The electroporation efficiency increased as the
DNA concentration increased from 5 to 50 mg. Electroporated clones could
be picked into 96-well plates, expanded, and successfully frozen/thawed.
Cell-Cycle Profiling
53 105 cells were harvested 1 day after passaging by dissociation with Accu-
tase (Sigma) and fixed in 70% ethanol at 4C. Cells were stained in a solution of
propidium iodide (10 mg/ml), RNase A (20 mg/ml) 0.1% BSA, and 0.1% Triton
X-1 in PBS for 30 min at 37C. Fluorescence was analyzed using a CyAn flow
cytometer (Dako). Data were analyzed using FlowJo software (v.8.4.6). Cell-
cycle distributions were calculated using a Watson pragmatic model.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, one
table, and nine figures and can be found with this article online at http://
www.cell.com/supplemental/S0092-8674(08).
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